China Regenerative Medicine International Limited ("CRMI") is principally engaged in R&D, production and distribution of bio-medical and healthcare products, consists of : 1) Cellular Therapy China Stem Cell Clinical Application Centre is currently built in Hong Kong, which complies with the highest standards set forth by EMA, US FDA and CFDA, set to be the world's leading GMP centre specializing in stem cell clinical applications and gene therapy, and a regional supply centre of cellular products for research, development and clinical purposes. Smaller scale but similar graded GMP cell processing facilities are operating in Suzhou, and will be serving in Tianjin, Shenzhen and others in the future. Inside those, we also provide adult tissue storage service for unmet medical needs. 2) Tissue Engineering Bio-Medical Devices We own three manufacturing plants in Xian and Shenzhen and successfully develop and launch : a) the world's unique acellular corneal stroma (Acornea) for laminar keratoplasty that can help corneal blindness patient restoring their vision b) tissue engineering skin (ActivSkin) which contain human live cell for burn skin and ulcer recovery c) Calcined Bovine Bone (CBB) which is bone generative powder for dental implantation and to treat periodontal defects d) Acellular Small Intestinal Submucosa (Resunin), which is for the repair of soft tissue in fistula to maintains the function of the anal sphincter e) Autologous Chondrocyte Implantation - Cell Sheet, which is the fourth generation technique to grow knee cartilage into cell sheet for reconstruction of knee function without prosthesis application. 3) Cosmetics & Healthcare Products Utilizing cell growth factors derived from TE process to develop avant-grade cosmetics & skincare products 4) Medical Equipment & Other Services 3D perfusion cell culture technology used in pre-clinical drug efficacy and toxicity testing and 3D perfusion bioreactors were developed and launched